Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:09 PM
Ignite Modification Date:
2025-12-24 @ 1:09 PM
NCT ID:
NCT01500161
Eligibility Criteria:
Inclusion Criteria:
* Patients \< 65 years with hematologic malignancies needing stem cell transplant but do not have HLA-matched sibling donor. Patients with the following diagnosis will be included:
* AML in first or subsequent complete or partial remissions
* ALL in first or subsequent complete or partial remissions
* CLL in second remission or more advanced disease
* CML who has failed tyrosine kinase inhibitors
* Hodgkin's disease who relapse after autologous transplant
* Non-Hodgkin's lymphoma who relapse after autologous transplant or NK-cell lymphoma in CR1
* Aplastic anemia patients
* Multiple myeloma in second remission or moer advanced disease, including those who have failed an autologous transplant
* Myelodysplastic syndrome in first or subsequent complete or partial remission
* Patients must have 6/6, 5/6 or 4/6 molecular matches from unrelated UCB donors. Matching will be done for A, B, and DR. Matching at DR will be confirmed by molecular typing.
* Patients must be documented to be HIV negative. Screening must have been performed within previous 6 months.
* Patients must be able to give written consent.
Exclusion Criteria:
* Patient is excluded if all of the Inclusion criteria above isn't met.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01500161
Study Brief:
Protocol Section:
NCT01500161